Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 104-112, March 2007

Effects of pharmacological intervention on arterial stiffness using pulse wave velocity measurement

  • Roland Asmar, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Roland Asmar, MD, The Cardiovascular Institute, 2, rue du Docteur Blanche, F-75016 Paris, France. Tel: +33 1 55 74 66 66; fax: +33 1 55 74 66 65.

The Cardiovascular Institute, Paris, France

Received 19 January 2007; accepted 19 January 2007.

Abstract 

Arterial stiffness is an independent and powerful marker of all-cause mortality and cardiovascular morbidity and mortality. Pharmacological studies have shown that it is feasible to improve arterial stiffness or to slow its progression with a number of lifestyle modifications or pharmacological agents including antihypertensive, statins, nitrates, and others. Therapeutic improvement of arterial stiffness has been reported to be associated with an improvement of cardiovascular prognosis. Assessment of pharmacological treatment on arterial stiffness needs to include several important aspects in order to avoid inadequate conclusions. Among these parameters: 1) the arterial site: effects of treatment may differ according to the arterial site with differences between radial (muscular) and carotid (elastic) artery; 2) the duration of treatment: long-term treatment is usually needed to assess the arterial effect; and 3) the dose of drug used is also of major importance: the dose-effect relationship varies for the same drug, whether the blood pressure reduction or the arterial effect is considered. In general, high doses are usually needed for the arterial wall property modification. This review is focused on the effects of major pharmacological treatment on arterial stiffness because it has been considered recently as the “gold standard”; effects on other arterial hemodynamic parameters such as central blood pressure are not reviewed.

Keywords: Compliance, large artery, antihypertensive therapy, hypocholesterolemia, statins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: none.

PII: S1933-1711(07)00037-X

doi:10.1016/j.jash.2007.01.007

Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 104-112, March 2007